| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/10/2011 | CN101475644B Novel targeted fusion protein with anti-inflammatory action and use thereof |
| 08/10/2011 | CN101473033B Method of transferring substance into cell |
| 08/10/2011 | CN101434962B Japanese blood fluke (Chinese mainland strain) tyrosine kinase TK4 conserved region gene, and cloning expression method and use thereof |
| 08/10/2011 | CN101394868B Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 08/10/2011 | CN101148466B RNA disturbance target point for inhibiting MDV proliferating and application thereof |
| 08/09/2011 | US7994362 Histone deacetylases, and uses related thereto |
| 08/09/2011 | US7994307 RNAi modulation of the BCR-ABL fusion gene and uses thereof |
| 08/09/2011 | US7994305 Small interfering RNA sequences for use in prevention and treatment of vision defects, inflammation, cardiovascular and cell proliferative disorders; RNA interference; gene expression inhibition |
| 08/09/2011 | US7994301 Modulators of body weight, corresponding nucleic acids and proteins |
| 08/09/2011 | US7994299 Compositions and methods for increasing bone mineralization |
| 08/09/2011 | US7994294 Nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 08/09/2011 | US7994292 MU-1, member of the cytokine receptor family |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994278 Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) |
| 08/09/2011 | US7994152 Method of treating a cancer by administering A 2′,5′-oligoadenylate analog |
| 08/09/2011 | US7994151 Compositions and methods for angiogenic therapy utilizing genes encoding ets-1 |
| 08/09/2011 | US7994150 Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof |
| 08/09/2011 | US7994147 Cellular genes regulated by HIV-1 infection and methods of use thereof |
| 08/09/2011 | US7994146 Method of enhancing an immune response |
| 08/09/2011 | US7994145 Bicyclonucleoside analogues |
| 08/09/2011 | US7994144 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme |
| 08/09/2011 | US7994116 Methods for reduction of adhesion formation using cytokine inhibitors |
| 08/09/2011 | US7994114 Chemokine mimetics synthesis and their use |
| 08/09/2011 | US7993924 Using myxoviral vector as somatic gene therapeutic tool; genetic vaccines |
| 08/09/2011 | US7993672 Stable lipid-comprising drug delivery complexes and methods for their production |
| 08/09/2011 | US7993651 Administering gag protein; vaccines for human immunodeficiency virus |
| 08/09/2011 | CA2567177C Genetically engineered cells for therapeutic applications |
| 08/09/2011 | CA2508281C Method for producing sterile polynucleotide based medicaments |
| 08/09/2011 | CA2438092C Ttk in diagnosis and as a therapeutic target in cancer |
| 08/09/2011 | CA2422078C High efficiency cardiac gene transfer |
| 08/09/2011 | CA2380058C Novel peptides |
| 08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
| 08/09/2011 | CA2332115C Aav structural protein, its preparation and use |
| 08/09/2011 | CA2253240C Hereditary hemochromatosis gene |
| 08/09/2011 | CA2243559C Pharmaceutical composition for immunomodulation |
| 08/04/2011 | WO2011094765A2 A targeting signal for integrating proteins, peptides and biological molecules into bacterial microcompartments |
| 08/04/2011 | WO2011094731A2 Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus |
| 08/04/2011 | WO2011094546A2 Oligonucleotides which inhibit p53 induction in response to cellular stress |
| 08/04/2011 | WO2011094446A1 A method for treating brain cancer using a novel tumor suppressor gene and secreted factor |
| 08/04/2011 | WO2011094358A1 Influenza nucleic acid molecules and vaccines made therefrom |
| 08/04/2011 | WO2011094352A1 In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation |
| 08/04/2011 | WO2011094335A2 Microrna signatures predicting responsiveness to anti-her2 therapy |
| 08/04/2011 | WO2011093470A1 Pharmaceutical composition for treatment of bone diseases, which contains protein comprising bone morphogenetic protein receptor 1b (bmpr1b) extracellular domain or mutant thereof |
| 08/04/2011 | WO2011070214A3 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 08/04/2011 | WO2011031482A3 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
| 08/04/2011 | WO2010129799A3 Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 08/04/2011 | US20110191874 Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system |
| 08/04/2011 | US20110190382 Treatment of Cancer by Inhibition of IGFBPs and Clusterin |
| 08/04/2011 | US20110190377 Method for producing a cell and/or tissue and/or disease phase specific medicament |
| 08/04/2011 | US20110190371 Genetic suppression and replacement |
| 08/04/2011 | US20110189224 Pestivirus replicons providing an rna-based viral vector system |
| 08/04/2011 | US20110189195 Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase |
| 08/04/2011 | US20110189193 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/04/2011 | US20110189182 Proteolytically cleavable fusion proteins with high molar specific activity |
| 08/04/2011 | CA2786901A1 Influenza nucleic acid molecules and vaccines made therefrom |
| 08/03/2011 | EP2351854A1 Coding sequences of the human BRCA1 gene |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351574A1 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue |
| 08/03/2011 | EP2351573A1 Neuregulin in the treatment of heart diseases |
| 08/03/2011 | EP2350297A2 Regeneration of pancreatic islets and reversal of diabetes by islet transcription factor genes delivered in vivo |
| 08/03/2011 | EP2350281A1 Multiple exon skipping compositions for dmd |
| 08/03/2011 | EP2350276A1 Syngr4 for target genes of cancer therapy and diagnosis |
| 08/03/2011 | EP2349348A2 Compositions and methods for reducing the signs of aging of the skin |
| 08/03/2011 | EP2349314A2 Lyophilized recombinant vwf formulations |
| 08/03/2011 | EP2349287A2 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53. |
| 08/03/2011 | EP2349210A2 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 08/03/2011 | EP1786905B1 Small interfering rna molecules against ribonucleotide reductase and uses thereof |
| 08/03/2011 | EP1620132B1 Biological pacemaker |
| 08/03/2011 | EP0784631B1 Method of producing a partial orf2 protein of hepatitis e virus |
| 08/03/2011 | CN102143761A Agent for treating myelofibrosis |
| 08/03/2011 | CN102140473A Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/03/2011 | CN102140471A Oligo-nucleic acid for suppressing tumor growth and application thereof |
| 08/03/2011 | CN102140470A Human miR-1236 antisense ribonucleic acid and application thereof |
| 08/03/2011 | CN102140469A Human miR (microRNA)-1233 antisensenucleic acid and application thereof |
| 08/03/2011 | CN102140468A Human miR-185* antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140467A Human miR-365 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140466A Human miR-1825 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140465A Human miR-1249 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140464A Human miR-1238 antisense nucleic acid and applications thereof |
| 08/03/2011 | CN102140463A Human miR (microRNA)-1296 antisensenucleic acid and application thereof |
| 08/03/2011 | CN102140462A Human miR-1260 antisense nucleic acid and application thereof |
| 08/03/2011 | CN102140461A Small interfering nucleic acid and medical composite and pharmaceutical applications of nucleic acid |
| 08/03/2011 | CN102140460A SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 08/03/2011 | CN102140459A SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 08/03/2011 | CN102140458A SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 08/03/2011 | CN102140441A Bird flu vaccine by using attenuated vaccinia Tian Tan as vector |
| 08/03/2011 | CN102139117A Application of TOB1 genes in preparation of medicaments for inhibiting breast cancer metastasis |
| 08/03/2011 | CN102139116A Preparation method of envelope protein A gene vaccine for fowl cholera |
| 08/03/2011 | CN102138889A Targeted drug-bearing ultrasonic microbubble and preparation method thereof |
| 08/02/2011 | US7989612 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | US7989584 AKT nucleic acids, polypeptides, and uses thereof |
| 08/02/2011 | US7989429 LNA antagonists targeting the androgen receptor |
| 08/02/2011 | US7989428 Combined telomerase inhibitor and gemcitabine for the treatment of cancer |
| 08/02/2011 | US7989427 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 08/02/2011 | US7989426 Selective induction of apoptosis to treat ocular disease by expression of PEDF |
| 08/02/2011 | US7989218 Protein fragment complementation assays for the detection of biological or drug interactions |
| 08/02/2011 | US7989203 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells |